Compare FLGT & ALTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FLGT | ALTI |
|---|---|---|
| Founded | 2011 | 2020 |
| Country | United States | United States |
| Employees | N/A | 490 |
| Industry | Medical Specialities | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 511.0M | 492.8M |
| IPO Year | 2016 | 2021 |
| Metric | FLGT | ALTI |
|---|---|---|
| Price | $21.71 | $3.06 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $28.33 | N/A |
| AVG Volume (30 Days) | ★ 274.5K | 158.2K |
| Earning Date | 05-01-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 41.11 |
| EPS | ★ N/A | N/A |
| Revenue | $18,730,000.00 | ★ $254,956,000.00 |
| Revenue This Year | $10.09 | $18.06 |
| Revenue Next Year | $12.18 | $10.71 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 23.21 |
| 52 Week Low | $13.46 | $2.75 |
| 52 Week High | $31.04 | $5.45 |
| Indicator | FLGT | ALTI |
|---|---|---|
| Relative Strength Index (RSI) | 61.46 | 35.27 |
| Support Level | $19.12 | $2.87 |
| Resistance Level | $21.56 | $3.97 |
| Average True Range (ATR) | 0.58 | 0.21 |
| MACD | 0.07 | -0.02 |
| Stochastic Oscillator | 79.41 | 14.29 |
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.
AlTi Global Inc is a wealth and investment partner to families, foundations, and institutions, helping clients activate capital, bring structure to complexity, and plan across borders and generations. The company combines the breadth of an international firm with the service offering of a family office to deliver solutions for wealth and capital. It provides services including discretionary and non-discretionary investment advisory, estate and wealth planning, trust and fiduciary, governance, philanthropy, and family office services, along with access to alternative investment opportunities. The company generates revenue from management, advisory, trustee, or administration fees, performance or incentive fees, distributions from investments, and other income or fees.